Literature DB >> 19208561

Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus.

Mandana Nikpour1, Dafna D Gladman, Dominique Ibañez, Ian N Bruce, Robert J Burns, Murray B Urowitz.   

Abstract

OBJECTIVE: Classic risk factors do not fully account for the increased risk of coronary artery disease (CAD) in systemic lupus erythematosus (SLE), making identification of the subset of patients at risk challenging. In this prospective cohort study we investigated whether myocardial perfusion defects in SLE are predictive of CAD events, independently of traditional Framingham risk factors.
METHODS: We performed myocardial perfusion imaging in 122 women with SLE who did not have a history of CAD. Patients had clinical and serologic evaluation, and an assessment of cardiac risk factors. They were then followed for the occurrence of CAD events. Cox regression models were used to determine independent predictors of CAD.
RESULTS: Forty-six (37.7%) patients had perfusion defects. Median followup was 8.7 years, during which 15 CAD events occurred (1 myocardial infarction, 14 angina). Cox modeling showed that myocardial perfusion defects are strongly predictive of CAD [hazard ratio (HR) 13.0, 95% CI 2.8 to 60.1, p = 0.001]. Although the 10-year Framingham risk score was significantly predictive of CAD (HR 1.8, 95% CI 1.1 to 2.9, p = 0.01), the risk scores in groups with normal and abnormal scans were similar to the "low-risk" general population.
CONCLUSION: In women with SLE, myocardial perfusion defects are strongly and independently predictive of CAD. Our findings suggest that myocardial perfusion imaging to assess risk of future coronary events should be considered in women with SLE.

Entities:  

Mesh:

Year:  2009        PMID: 19208561     DOI: 10.3899/jrheum.080776

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

2.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

3.  High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function.

Authors:  J M Sabio; Carlos Garcia-de Los Ríos; Marta Medina-Casado; María Del Mar Del Águila-García; Rafael Cáliz-Cáliz; Antonio Díaz-Chamorro
Journal:  Rheumatol Int       Date:  2022-09-12       Impact factor: 3.580

4.  Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study.

Authors:  Mandana Nikpour; Dafna D Gladman; Dominique Ibanez; Paula J Harvey; Murray B Urowitz
Journal:  Arthritis Res Ther       Date:  2010-06-30       Impact factor: 5.156

Review 5.  Epidemiology of atherosclerosis in systemic lupus erythematosus.

Authors:  Mandana Nikpour; Murray B Urowitz; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

6.  Echocardiographic strain analysis reflects impaired ventricular function in youth with pediatric-onset systemic lupus erythematosus.

Authors:  Joyce C Chang; Yan Wang; Rui Xiao; Anysia Fedec; Kevin E Meyers; Craig Tinker; Shobha S Natarajan; Andrea M Knight; Pamela F Weiss; Laura Mercer-Rosa
Journal:  Echocardiography       Date:  2020-10-03       Impact factor: 1.724

Review 7.  Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Authors:  Vítor Teixeira; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2018-01-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.